参考文献/References:
[1] BONFIGLIO V,REIBALDI M,PIZZO A,RUSSO A,MACCHI I,FARO G,et al.Dexamethasone for unresponsive diabetic macular oedema:optical coherence tomography biomarkers[J].Acta Ophthalmol,2019,97(4):e540-e544.
[2] CHATZIRALLI I,THEODOSSIADIS P,PARIKAKIS E,DIMITRIOU E,XIROU T,THEODOSSIADIS G,et al.Dexamethasone intravitreal implant in diabetic macular edema:real-life data from a prospective study and predictive factors for visual outcome[J].Diabetes Ther,2017,8(6):1393-1404.
[3] DEAK G G,BOLZ M,RITTER M,PRAGER S,BENESCH T,SCHMIDT-ERFURTH U.A systematic correlation between morphology and functional alterations in diabetic macular edema[J].Invest Ophthalmol Vis Sci,2010,51(12):6710-6714.
[4] GERENDAS B S,PRAGER S,DEAK G,SIMADER C,LAMMER J,WALDSTEIN S M,et al.Predictive imaging biomarkers relevant for functional and anatomical outcomes during ranibizumab therapy of diabetic macular oedema[J].Br J Ophthalmol,2018,102(2):195-203.
[5] REZNICEK L,CSERHATI S,SEIDENSTICKER F,LIEGL R,KAMPIK A,ULBIG M,et al.Functional and morphological changes in diabetic macular edema over the course of anti-vascular endothelial growth factor treatment[J].Acta Ophthalmol,2013,91(7):e529- e536.
[6] KARST S G,LAMMER J,MITSCH C,SCHOBER M,MEHTA J,SCHOLDA C,et al.Detailed analysis of retinal morphology in patients with diabetic macular edema randomized to ranibizumab or triamcinolone treatment[J].Graefes Arch Clin Exp Ophthalmol,2018,256(1):49-58.
[7] ARF S,SAYMAN M I,HOCAOGLU M,ERSOZ M G,OZDEMIR H,KARACORLU M.Spectral domain optical coherence tomography classification of diabetic macular edema:a new proposal to clinical practice[J].Graefes Arch Clin Exp Ophthalmol,2020,258(6):1165-1172.
[8] GAUCHER D,SEBAH C,ERGINAY A,HAOUCHINE B,TADAYONI R,GAUDRIC A,et al.Optical coherence tomography features during the evolution of serous retinal detachment in patients with diabetic macular edema[J].Am J Ophthalmol,2008,145(2):289-296.
[9] CAMPOS A,CAMPOS E J,MARTINS J.Viewing the choroid:where we stand,challenges and contradictions in diabetic retinopathy and diabetic macular oedema[J].Acta Ophthalmol,2017,95(5):446-459.
[10] VUJOSEVIC S,TORRESIN T,BERTON M,BINI S,CONVENTO E,MIDENA E.Diabetic macular edema with and without subfoveal neuroretinal detachment:two different morphologic and functional entities[J].Am J Ophthalmol,2017,181:149-155.
[11] SHIMURA M,YASUDA K,YASUDA M,NAKAZAWA T.Visual outcome after intravitreal bevacizumab depends on the optical coherence tomographic patterns of patients with diffuse diabetic macular edema[J].Retina,2013,33(4):740-747.
[12] ERCALIK N Y,IMAMOGLU S,TURKSEVEN K E,YENEREL N M,BARDAK H,BARDAK Y.Influence of serous retinal detachment on the outcome of ranibizumab treatment in diabetic macular oedema[J].Cutan Ocul Toxicol,2018,37(4):324-327.
[13] KALDIRIM H,YAZGAN S,KIRGIZ A,ATALAY K,SAVUR F.A comparison study of ranibizumab and aflibercept in patients with naive diabetic macular edema in presence of serous retinal detachment[J].Curr Eye Res,2019,44(9):987-993.
[14] BOLUKBASI S,CAKIR A,ERDEN B,KARACA G.Comparison of the short-term effect of aflibercept and dexamethasone implant on serous retinal detachment in the treatment of naive diabetic macular edema[J].Cutan Ocul Toxicol,2019,38(4):401-405.
[15] WONG Y,STEEL D H W,HABIB M S,STUBBING-MOORE A,BAJWA D,AVERY P J.Vitreoretinal interface abnormalities in patients treatedwith ranibizumab for diabetic macular oedema[J].Graefes Arch Clin Exp Ophthalmol,2017,255(4):733-742.
[16] SADIQ M A,SOLIMAN M K,SARWAR S,AGARWAL A,HANOUT M,DEMIREL S,et al.Effect of vitreomacular adhesion on treatment outcomes in the ranibizumab for edema of the macula in diabetes (READ-3) study[J].Ophthalmology,2016,123(2):324-329.
[17] KULIKOV A N,SOSNOVSKII S V,BEREZIN R D,MALTSEV D S,OSKANOV D H,GRIBANOV N A.Vitreoretinal interface abnormalities in diabetic macular edema and effectiveness of anti-VEGF therapy:an optical coherence tomography study[J].Clin Ophthalmol,2017,11:1995-2002.
[18] SUN J K,LIN M M,LAMMER J,PRAGER S,SARANGI R,SILVA P S,et al.Disorganization of the retinal inner layers as a predictor of visual acuity in eyes with center-involved diabetic macular edema[J].JAMA Ophthalmol,2014,132 (11):1309-1316.
[19] DAS R, SPENCE G, HOGG R E, STEVENSON M,CHAKRAVARTHY U.Disorganization of inner retina and outer retinal morphology in diabetic macular edema[J].JAMA Ophthalmol,2018,136(2):202-208.
[20] PELOSINI L,HULL C C,BOYCE J F,MCHUGH D,STANFORD M R,MARSHALL J.Optical coherence tomography may be used to predict visual acuity in patients with macular edema[J].Invest Ophthalmol Vis Sci,2011,52(5):2741-2748.
[21] BALARATNASINGAM C,INOUE M,AHN S,MCCANN J,DHRAMI-GAVAZI E,YANNUZZI L A,et al.Visual acuity is correlated with the area of the foveal avascular zone in diabetic retinopathy and retinal vein occlusion[J].Ophthalmology,2016,123(11):2352-2367.
[22] SPAIDE R F.Volume-rendered optical coherence tomography of diabetic retinopathy pilot study[J].Am J Ophthalmol,2015,160(6):1200-1210.
[23] SAXENA S,RUIA S,PRASAD S,JAIN A,MISHRA N,NATU S M,et al.Increased serum levels of urea and creatinine are surrogate markers for disruption of retinal photoreceptor external limiting membrane and inner segment ellipsoid zone in type 2 diabetes mellitus[J].Retina,2017,37:344-349.
[24] SHEN Y,LIU K,XU X.Correlation between visual function and photoreceptor integrity in diabetic macular edema:spectral-domain optical coherence tomography[J].Curr Eye Res,2016,41(3):391-399.
[25] MAHESHWARY A S,OSTER S F,YUSON R M,CHENG L,MOJANA F,FREEMAN W R.The association between percent disruption of the photoreceptor imaer segment-outer segment junction and visual acuity in diabetic macular edema[J].Am J Ophthahnology,2010,150(1):63-67.
[26] DE S,SAXENA S,KAUR A,MAHDI A A,MISRA A,SINGH M,et al.Sequential restoration of external limiting membrane and ellipsoid zone after intravitreal anti-VEGF therapy in diabetic macular oedema[J].Eye,2021,35(5):1490-1495.
[27] OZKAYA A,ALKIN Z,KARAKUCUK Y,KARATAS G,FAZIL K,ERDOGAN M G,et al.Thickness of the retinal photoreceptor outer segment layer in healthy volunteers and in patients with diabetes mellitus without retinopathy,diabetic retinopathy,or diabetic macular edema[J].Saudi J Ophthalmol,2017,31:69-75.
[28] CHUNG Y R,LEE S Y,KIM Y H,BYEON H E,KIM J H,LEE K.Hyperreflective foci in diabetic macular edema with serous retinal detachment:association with dyslipidemia[J].Acta Diabetol,2020,57(7):861-866.
[29] BOLZ M,SCHMIDT-ERFURTH U,DEAK G,MYLONAS G,KRIECHBAUM K,SCHOLDA C.Optical coherence tomographic hyperreflective foci:a morphologic sign of lipid extravasation in diabetic macular edema [J].Ophthalmology,2009,116(5):914-920.
[30] UJI A,MURAKAMI T,NISHIJIMA K,AKAGI T,HORII T,ARAKAWA N,et al.Association between hyperreflective foci in the outer retina,status of photoreceptor layer,and visual acuity in diabetic macular edema[J].Am J Ophthalmol,2012,153(4):710-717.
[31] ZUR D,IGLICKI M,BUSCH C,INVERNIZZI A,MARIUSSI M,LOEWENSTEIN A.OCT biomarkers as functional outcome predictors in diabetic macular edema treated with dexamethasone implant.International Retina Group[J].Ophthalmology,2018,125(2):267-275.
[32] HWANG H S,CHAE J B,KIM J Y,KIM D Y.Association between hyperreflective dots on spectral-domain optical coherence tomography in macular edema and response to treatment[J]. Invest Ophthalmol Vis Sci,2017,58(13):5958-5967.
[33] LIU S,WANG D,CHEN F.Hyperreflective foci in OCT image as a biomarker of poor prognosis in diabetic macular edema patients treating with conbercept in China[J].BMC Ophthalmol,2019,19(1):157.
[34] KANG J W,CHUNG H,CHAN K H.Correlation of optical coherence tomographic hyperreflective foci with visual outcomes in different patterns of diabetic macular edema[J].Retina,2016,36(9):1630-1639.
[35] YOSHITAKE T,MURAKAMI T,SUZUMA K,DODO Y,FUJIMOTO M,TSUJIKAWA A.Hyperreflective foci in the outer retinal layers as a predictor of the functional efficacy of ranibizumab for diabetic macular edema[J].Sci Rep,2020,10(1):873.
[36] MARKAN A,AGARWAL A,ARORA A,BAZGAIN K,RANA V,GUPTA V.Novel imaging biomarkers in diabetic retinopathy and diabetic macular edema[J].Ther Adv Ophthalmol,2020,12:2515841420950513.
[37] ROY R,SAURABH K,SHAH D,CHOWDHURY M,GOEL S.Choroidal hyperreflective foci:a novel spectral domain optical coherence tomography biomarker in eyes with diabetic macular edema[J].Asia Pac J Ophthalmol (Phila),2019,8:314-318.
[38] WANG W,LIU S,QIU Z,HE M,WANG L,LI Y,et al.Choroidal thickness in diabetes and diabetic retinopathy:a swept source OCT study[J].Invest Ophthalmol Vis Sci,2020,61(4):29.
[39] ELIWA T F,HEGAZY O S,MAHMOUD S S,ALMAAMON T.Choroidal thickness change in patients with diabetic macular edema[J].Ophthalmic Surg Lasers Imaging Retina,2017,48:970-977.
[40] ABADIA B,SUNEN I,CALVO P,BARTOL F,VERDES G,FERRERAS A.Choroidal thickness measured using swept-source optical coherence tomography is reduced in patients with type 2 diabetes[J].PLoS One,2018,13(2):e0191977.
[41] GUPTA C,TAN R,MISHRA C,KHANDELWAL N,RAMAN R,KIM R,et al.Choroidal structural analysis in eyes with diabetic retinopathy and diabetic macular edema-a novel OCT based imaging biomarker[J].PLoS One,2018,13(12):e0207435.
[42] KIM J T,LEE D H,JOE S G,KIM J G,YOON Y H.Changes in choroidal thickness in relation to the severity of retinopathy and macular edema in type 2 diabetic patients[J].Invest Ophthalmology Visual Sci,2013,54:3378-3384.
[43] AKSOY M,YILMAZ G,VARDARLI I,AKKOYUN I.Choroidal thickness after dexamethasone implant or aflibercept in patients with diabetic macular edema persistent to ranibizumab[J].J Ocul Pharmacol Ther,2020,36(8):629-635.
[44] KIM M,CHOI S Y,PARK Y H.Quantitative analysis of retinal and choroidal microvascular changes in patients with diabetes[J].Sci Rep,2018,8(1):12146.
[45] DI G,WEIHONG Y,XIAO Z,ZHIKUN Y,XUAN Z,YI Q,et al.A morphological study of the foveal avascular zone in patients with diabetes mellitus using optical coherence tomography angiography[J].Graefe’s Arch Clin Exp Ophthalmol,2016,254(5):873-879.
[46] ATTAALLAH H R,MOHAMED A A M,ALI M A.Macular vessels density in diabetic retinopathy:quantitative assessment using optical coherence tomography angiography[J].Int Ophthalmol,2019,39(8):1845-1859.
[47] LEE J,MOON B G,CHO A R,YOON Y H.Optical coherence tomography angiography of dme and its association with anti-VEGF treatment response[J].Ophthalmology,2016,123(11):2368-2375.
[48] MOON B G,UM T,LEE J,YOON Y H.Correlation between deep capillary plexus perfusion and long-term photoreceptor recovery after diabetic macular edema treatment[J].Ophthalmol Retina,2018,2(3):235-243.
[49] DASTIRIDOU A,KARATHANOU K,RIGA P,ANAGNOSTOPOULOU S,BALASUBRAMANIAN S,MATAFTSI A,et al.OCT angiography study of the macula in patients with diabetic macular edema treated with intravitreal aflibercept[J].Ocul Immunol Inflamm,2021,29(5):926-931.
[50] GILL A,COLE E D,NOVAIS E A,LOUZADA R N,DE C T,DUKER J S,et al.Visualization of changes in the foveal avascular zone in both observed and treated diabetic macular edema using optical coherence tomography angiography[J].Int J Retina Vitreous,2017,3:19.
[51] MASTROPASQUA R,TOTO L,MASTROPASQUA A,ALOIA R,DE N C,MATTEI P A,et al.Foveal avascular zone area and parafoveal vessel density measurements in differrent stages of diabetic retinopathy by optical coherence tomography angiography[J].Int J Ophthalmol,2017,10(10):1545-1551.
[52] SAMBHAV K,ABU-AMERO K K,CHALAM K V.Deep capillary macular perfusion indices obtained with OCT angiography correlate with degree of nonproliferative diabetic retinopathy[J].Eur J Ophthalmol,2017,27(6):716-729.
[53] TOTO L,DALOISIO R,DI N M,DI M G,DI S S,CIANCAGLINI M,et al.Qualitative and quantitative assessment of vascular changes in diabetic macular edema after dexamethasone implant using optical coherence tomography angiography[J].Int J Mol Sci,2017,18(6):1181.
[54] BUSCH C,WAKABAYASHI T,SATO T,FUKUSHIMA Y,HARA C,SHIRAKI N,et al.Retinal microvasculature and visual acuity after intravitreal aflibercept in diabetic macular edema:an optical coherence tomography angiography study[J].Sci Rep,2019,9(1):1561.
[55] SOROUR O A,SABROSA A S,YASIN A A,ARYA M,ISHIBAZAWA A,WITKIN A J,et al.Optical coherence tomography angiography analysis of macülar vessel density before and after anti-VEGF therapy in eyes with diabetic retinopathy[J].Int Ophthalmol,2019,39(10):2361-2371.
[56] COUTURIER A,MANE V,BONNIN S,ERGINAY A,MASSIN P,GAUDRIC A,et al.Capillary plexus anomalies in diabetic retinopathy on optical coherence tomography angiography[J].Retina,2015,35(11):2384-2391.
[57] ISHIBAZAWA A,NAGAOKA T,TAKAHASHI A,OMAE T,TANI T,SOGAWA K,et al.Optical coherence tomography angiography in diabetic retinopathy:a prospective pilot study[J].Am J Ophthalmol,2015,160(1):35-44.
[58] HARITOGLOU C,KERNT M,NEUBAUER A,GERSS J,OLIVEIRA C M,KAMPIK A,et al.Microaneurysm formation rate as a predictive marker for progression to clinically significant macular edema in nonproliferative diabetic retinopathy[J].Retina,2014,34(1):157-164.
[59] HASEGAWA N,NOZAKI M,TAKASE N,YOSHIDA M,OGURA Y.New insights into microaneurysms in the deep capillary plexus detected by optical coherence tomography angiography in diabetic macular edema[J].Invest Ophthalmol Vis Sci,2016,57(9):348-355.
[60] GHASEMI F K,IAFE N A,HUBSCHMAN J P,TSUI I,SADDA S R,SARRAF D.Optical coherence tomography angiography analysis of the foveal avascular zone and macular vessel density after anti-VEGF therapy in eyes with diabetic macular edema and retinal vein occlusion[J].Invest Ophthalmol Vis Sci,2017,58(1):30-34.